
Wall Street Week
Wall Street Week tells the stories of capitalism from around the world, hosted by David Westin in New York.
Latest episodes

9 snips
Apr 3, 2025 • 22min
Trump Tariffs: Everything You Need to Know
President Trump’s recent tariff announcements have sent shockwaves through global markets and sparked heated debates. The proposed 10% tariffs aim to reshape trade relationships, particularly with China and the EU. Supporters hail it as a win for American workers, while critics warn of escalating trade tensions and economic repercussions. Insights from political figures reveal deep divides within the Republican Party over these policies. The podcast delves into potential retaliatory actions and their impact on consumer prices and domestic industries.

9 snips
Mar 28, 2025 • 36min
Playing Offense and Defense | European defense spending, corporate reinvention, business of video games
Zannie Mitten-Bettos, Editor-in-chief of The Economist, discusses the rising tensions between the US and Europe, particularly on defense spending amidst geopolitical shifts. Joe Preston, CEO of New Balance, shares how the brand has revitalized itself through strategic pivots and a focus on U.S. manufacturing. The conversation also dives into the booming $200 billion video game market, highlighting the anticipation around upcoming titles like Grand Theft Auto 6, illustrating the industry's balance between creativity and commercial success.

Mar 24, 2025 • 30sec
Introducing: Stock Movers
Dive into the latest stock market movements, exploring the highs and lows of popular companies. Gain insights into the performance of key players in the aluminum and steel industries. Discover the challenges confronting crypto companies and stay ahead with quick updates on essential market trends. Perfect for those looking to enhance their investment knowledge in a snap!

Mar 21, 2025 • 35min
Summers on the Fed, US Energy Policy, and Death by Bandwagon
Lawrence H. Summers, former U.S. Treasury Secretary, critiques President Trump's economic policies as self-inflicted wounds. He delves into the tension between government drilling initiatives and the oil industry's hesitance to ramp up production due to market pressures. Scott Sheffield, CEO of Pioneer Natural Resources, discusses the complexities of energy policy amid inflation challenges. Both guests highlight the risks of blindly following trends in economic and energy strategies, urging a more nuanced approach to policy-making and production.

Mar 14, 2025 • 36min
Revisiting the past and second acts | 5-year anniversary of Covid-19, New ventures of former Netflix CEO Reed Hastings
This week, we look at five years since Covid-19...what has changed? What did we expect would change? And, how did different governments' pandemic restrictions affect their economies? Plus, did you ever wonder what CEOs do after they retire? We sit down with former Netflix CEO Reed Hastings on his new ski town.See omnystudio.com/listener for privacy information.

Mar 8, 2025 • 48min
Not-so-alternative investing | China's economic challenges, Investing in women's sports, Sports as an asset class, Faith-based investing
Elizabeth Economy, a Senior Fellow at the Hoover Institution, dives into China’s economic hurdles and its strategic shifts during the two-sessions meeting. She explores the dual circulation policy and the country’s drive for innovation amid U.S. competition. The discussion shifts to the booming investment landscape in women’s sports, spotlighting leagues like the WNBA and NWSL, driven by rising viewership and sponsorships. Lastly, the role of faith in investments is examined, revealing how personal beliefs are increasingly influencing financial choices.

12 snips
Mar 1, 2025 • 38min
Staying Above Water | India-US relations, the luxury industry reimagined, trouble with regulation, zombie companies
India's growth story faces complexities as US relations shift. The luxury industry grapples with sustainability and the rise of secondhand retail as potential saviors. There's an intriguing discussion on deregulation and its mixed effects. Plus, the fate of 'zombie companies' is examined, highlighting the struggles and comebacks of brands like Barnes & Noble. Insights into the detection of these struggling firms reveal key financial indicators that could signal their fate.

Feb 22, 2025 • 35min
What's in a name? | Tariffs hit autos, naming the Inflation Reduction Act, AI hurdles
This week, the discussion dives into the impact of proposed tariffs on U.S. automakers, sparking concerns over job losses and financial strain. There's a critical look at whether the Inflation Reduction Act has truly lived up to its promises. The conversation extends to artificial intelligence, highlighting both its rising potential and the significant hurdles it faces. Insights from Nobel Laureate Geoffery Hinton reveal the pressing need for AI regulation as the tech landscape rapidly evolves.

Feb 15, 2025 • 35min
Laser-focused on deals | Trump's negotiating style, prediction markets, methane emissions
Howard Dieter, vice president of environmental health and safety at Jonah Energy, discusses groundbreaking laser technology for detecting methane leaks in Wyoming's natural gas industry. The importance of addressing methane emissions is highlighted as both an environmental and economic challenge. Dieter explains how proactive monitoring can enhance compliance and market competitiveness, showcasing innovative solutions that could revolutionize the industry and help mitigate climate change.

Feb 8, 2025 • 38min
Spending on the Right Things: Future of Cancer, Alzheimer's, Global Debt Cycles
Albert Bourla, CEO of Pfizer, discusses the company's focus on innovative cancer treatments and the role of AI in drug development. Ray Dalio shares insights on rising global debt, urging smart management for economic stability. Matthew Schrag, a neurologist at Vanderbilt, raises red flags about research integrity in Alzheimer's treatments, stressing the urgent need for accountability in scientific studies. Together, they explore the intersection of healthcare innovation and economic challenges, emphasizing the importance of prioritizing effective therapies.